BRD7 and neoplasm: In addition, in ovarian cancer, BRD7 is expressed at a low level, inhibits tumor growth and invasion and potently accelerates the apoptosis of ovarian cancer cells through inhibition of the nuclear entry of β-catenin in a p53-independent manner [16].